Safety study of R-3750 for mild to moderate COPD
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests an experimental medicine called R-3750 to see if it is safe and helpful for people with mild to moderate COPD. It is an early-phase trial, so the main goal is safety, but they will also look at how your breathing responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You must have had a doctor's diagnosis of COPD for at least a year.
- Your breathing tests must show mild to moderate COPD (not severe).
- You must have had at least one COPD flare-up in the past year.
- You need a smoking history of at least 10 pack-years (for example, smoking a pack a day for 10 years).
- You must be on a stable COPD medication regimen for at least 4 weeks before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This trial tests an experimental drug called R-3750 for people with a severe lung condition called ARDS that has not improved after at least a week. The drug is given through a tube into the stomach, and the goal is to see if it can help the lungs recover.
Hear when a new COPD Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.